Previous studies about LGALS3BP in CHB and HCC found its different expression on transcriptional level [78], while in current study we identified its protein was differentially expressed in CHB patients and had the potential to be a good marker for LSSD-CHB subtype. Here, LGALS3BP is linked to hepatocellular carcinoma.